Exact Mass: 439.2403

Exact Mass Matches: 439.2403

Found 149 metabolites which its exact mass value is equals to given mass value 439.2403, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Leukotriene E4

(5S-(5R*,6S*(s*),7E,9E,11Z,14Z))-6-((2-amino-2-carboxyethyl)thio)-5-hydroxy-7,9,11,14-eicosatetraenoic acid

C23H37NO5S (439.2392)


Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4 activates contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent and are able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways. Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078)

   

Militarinone B

Militarinone B

C26H33NO5 (439.2359)


A natural product found in Isaria farinosa.

   

11-trans-LTE4

(5S,6R,7E,9E,11E,14Z)-6-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid

C23H37NO5S (439.2392)


11-trans-LTE4 is also known as 11-trans-Leukotriene e4 or 11t-LTE4. 11-trans-LTE4 is considered to be practically insoluble (in water) and acidic. 11-trans-LTE4 is an eicosanoid lipid molecule

   

(5S,6R,7E,9E,11Z,14Z)-6-((R)-2-Amino-2-carboxyethylthio)-5-hydroxyicosa-7,9,11,14-tetraenoic acid

(5S,6R,7E,9E,11Z,14Z)-6-((R)-2-Amino-2-carboxyethylthio)-5-hydroxyicosa-7,9,11,14-tetraenoic acid

C23H37NO5S (439.2392)


   

Nvp-aew541

7-{3-[(azetidin-1-yl)methyl]cyclobutyl}-5-[3-(benzyloxy)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine

C27H29N5O (439.2372)


   

Salicylihalamide A

Salicylihalamide A

C26H33NO5 (439.2359)


   

(E,E)-Numismine|1,29-Seco-lunarin|1,29-seco-lunarine|Numismin|numismine

(E,E)-Numismine|1,29-Seco-lunarin|1,29-seco-lunarine|Numismin|numismine

C25H33N3O4 (439.2471)


   

lannotinidine D

lannotinidine D

C26H33NO5 (439.2359)


   
   

Dexymalyngamide C

Dexymalyngamide C

C24H38ClNO4 (439.2489)


   

Scutebarbatine Z

Scutebarbatine Z

C26H33NO5 (439.2359)


   

deoxymalyngamide C

deoxymalyngamide C

C24H38ClNO4 (439.2489)


   
   
   

NVP-AEW541

7-[cis-3-(1-azetidinylmethyl)cyclobutyl]-5-[3-(phenylmethoxy)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine, dihydrochloride

C27H29N5O (439.2372)


   

EXE4;14,15-LTE4

EXE4;14,15-LTE4

C23H37NO5S (439.2392)


   
   
   
   

Ile Asn Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Ile Pro Asn Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Ile Pro Pro Asn

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C20H33N5O6 (439.2431)


   

Leu Asn Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Leu Pro Asn Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Leu Pro Pro Asn

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C20H33N5O6 (439.2431)


   

Asn Ile Pro Pro

(2S)-1-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Asn Leu Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Asn Pro Ile Pro

(2S)-1-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Asn Pro Leu Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Asn Pro Pro Ile

(2S,3S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H33N5O6 (439.2431)


   

Asn Pro Pro Leu

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H33N5O6 (439.2431)


   

Pro Ile Asn Pro

(2S)-1-[(2S)-3-carbamoyl-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Pro Ile Pro Asn

(2S)-3-carbamoyl-2-{[(2S)-1-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H33N5O6 (439.2431)


   

Pro Leu Asn Pro

(2S)-1-[(2S)-3-carbamoyl-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Pro Leu Pro Asn

(2S)-3-carbamoyl-2-{[(2S)-1-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H33N5O6 (439.2431)


   

Pro Asn Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Pro Asn Leu Pro

(2S)-1-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Pro Asn Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H33N5O6 (439.2431)


   

Pro Asn Pro Leu

(2S)-2-{[(2S)-1-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H33N5O6 (439.2431)


   

Pro Pro Ile Asn

(2S)-3-carbamoyl-2-[(2S,3S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamido]propanoic acid

C20H33N5O6 (439.2431)


   

Pro Pro Leu Asn

(2S)-3-carbamoyl-2-[(2S)-4-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamido]propanoic acid

C20H33N5O6 (439.2431)


   

Pro Pro Asn Ile

(2S,3S)-2-[(2S)-3-carbamoyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]-3-methylpentanoic acid

C20H33N5O6 (439.2431)


   

Pro Pro Asn Leu

(2S)-2-[(2S)-3-carbamoyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]-4-methylpentanoic acid

C20H33N5O6 (439.2431)


   

Pro Pro Gln Val

(2S)-2-[(2S)-4-carbamoyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]-3-methylbutanoic acid

C20H33N5O6 (439.2431)


   

Pro Pro Val Gln

(2S)-4-carbamoyl-2-[(2S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]butanoic acid

C20H33N5O6 (439.2431)


   

Pro Gln Pro Val

(2S)-2-{[(2S)-1-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H33N5O6 (439.2431)


   

Pro Gln Val Pro

(2S)-1-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Pro Val Pro Gln

(2S)-4-carbamoyl-2-{[(2S)-1-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}butanoic acid

C20H33N5O6 (439.2431)


   

Pro Val Gln Pro

(2S)-1-[(2S)-4-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Gln Pro Pro Val

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H33N5O6 (439.2431)


   

Gln Pro Val Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Gln Val Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Val Pro Pro Gln

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C20H33N5O6 (439.2431)


   

Val Pro Gln Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

Val Gln Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H33N5O6 (439.2431)


   

11-trans-LTE4

5S-hydroxy-6R-(S-cysteinyl)-7E,9E,11E14Z-eicosatetraenoic acid

C23H37NO5S (439.2392)


A leukotriene that is the 11-trans-isomer of leukotriene E4.

   

14,15-Leukotriene E4

15S-hydroxy-14R-(S-cysteinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid

C23H37NO5S (439.2392)


   

14,15-LTE4

15S-hydroxy-14R-(S-cysteinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid

C23H37NO5S (439.2392)


   
   

Leukotriene E

5S-hydroxy-6R-(S-cysteinyl),7E,9E,11Z,14Z-eicosatetraenoic acid

C23H37NO5S (439.2392)


A leukotriene that is (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid substituted by a hydroxy group at position 5 (5S) and an L-cystein-S-yl group at position 6 (6R).

   

Proversilin C

Proversilin C

C26H33NO5 (439.2359)


   

Proversilin D

Proversilin D

C26H33NO5 (439.2359)


   

1-(1-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-1-((TERT-BUTYLDIMETHYLSILYL)OXY)PROPAN-2-YL)-3-(M-TOLYL)UREA

1-(1-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-1-((TERT-BUTYLDIMETHYLSILYL)OXY)PROPAN-2-YL)-3-(M-TOLYL)UREA

C23H33N5O2Si (439.2403)


   

{1-[2-Oxo-2-({4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl}amino)ethyl]cyclopentyl}acetic acid hydrochloride (1:1)

{1-[2-Oxo-2-({4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl}amino)ethyl]cyclopentyl}acetic acid hydrochloride (1:1)

C21H34ClN5O3 (439.235)


   

1,5-diphenyl-2-[3-(4-pyridin-2-ylpiperazin-1-yl)propyl]pyrazol-3-one

1,5-diphenyl-2-[3-(4-pyridin-2-ylpiperazin-1-yl)propyl]pyrazol-3-one

C27H29N5O (439.2372)


   

Temiverine hydrochloride hydrate

Temiverine hydrochloride hydrate

C24H38ClNO4 (439.2489)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

N-(2-phenylphenyl)-8-(4-pyridin-3-yltriazol-1-yl)octanamide

N-(2-phenylphenyl)-8-(4-pyridin-3-yltriazol-1-yl)octanamide

C27H29N5O (439.2372)


   

2-(2,4-Dichlorobenzyloxy)aniline

2-(2,4-Dichlorobenzyloxy)aniline

C23H37NO5S (439.2392)


   

7-[3-(1-Azetidinylmethyl)cyclobutyl]-5-(4-phenylmethoxyphenyl)-4-pyrrolo[2,3-d]pyrimidinamine

7-[3-(1-Azetidinylmethyl)cyclobutyl]-5-(4-phenylmethoxyphenyl)-4-pyrrolo[2,3-d]pyrimidinamine

C27H29N5O (439.2372)


   

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(5R,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(5R,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

1-[(1R)-2-[cyclopentyl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

1-[(1R)-2-[cyclopentyl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

C25H33N3O4 (439.2471)


   

(6S,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-7-[4-(1-cyclohexenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H33N3O4 (439.2471)


   

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C25H33N3O4 (439.2471)


   

N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C25H33N3O4 (439.2471)


   

(1S,9R,10R,11R)-12-(cyclobutanecarbonyl)-10-(hydroxymethyl)-11-(piperidine-1-carbonyl)-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

(1S,9R,10R,11R)-12-(cyclobutanecarbonyl)-10-(hydroxymethyl)-11-(piperidine-1-carbonyl)-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C25H33N3O4 (439.2471)


   

(1R,9S,10S,11S)-12-(cyclobutanecarbonyl)-10-(hydroxymethyl)-11-(piperidine-1-carbonyl)-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

(1R,9S,10S,11S)-12-(cyclobutanecarbonyl)-10-(hydroxymethyl)-11-(piperidine-1-carbonyl)-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C25H33N3O4 (439.2471)


   

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] dodecanoate

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] dodecanoate

C19H38NO8P (439.2335)


   

Lnape 7:0/N-7:0

Lnape 7:0/N-7:0

C19H38NO8P (439.2335)


   

Lnape 6:0/N-8:0

Lnape 6:0/N-8:0

C19H38NO8P (439.2335)


   

Lnape 9:0/N-5:0

Lnape 9:0/N-5:0

C19H38NO8P (439.2335)


   

Lnape 5:0/N-9:0

Lnape 5:0/N-9:0

C19H38NO8P (439.2335)


   

Lnape 8:0/N-6:0

Lnape 8:0/N-6:0

C19H38NO8P (439.2335)


   

Lnape 3:0/N-11:0

Lnape 3:0/N-11:0

C19H38NO8P (439.2335)


   

Lnape 10:0/N-4:0

Lnape 10:0/N-4:0

C19H38NO8P (439.2335)


   

Lnape 2:0/N-12:0

Lnape 2:0/N-12:0

C19H38NO8P (439.2335)


   

Lnape 4:0/N-10:0

Lnape 4:0/N-10:0

C19H38NO8P (439.2335)


   

Lnape 12:0/N-2:0

Lnape 12:0/N-2:0

C19H38NO8P (439.2335)


   

Lnape 11:0/N-3:0

Lnape 11:0/N-3:0

C19H38NO8P (439.2335)


   

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-heptanoyloxypropyl] heptanoate

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-heptanoyloxypropyl] heptanoate

C19H38NO8P (439.2335)


   

(2-Hexanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C19H38NO8P (439.2335)


   

(3-Acetyloxy-2-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Acetyloxy-2-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C19H38NO8P (439.2335)


   

(2-Octanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Octanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C19H38NO8P (439.2335)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] nonanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] nonanoate

C19H38NO8P (439.2335)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] octanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] octanoate

C19H38NO8P (439.2335)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] undecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] undecanoate

C19H38NO8P (439.2335)


   

(3-Butanoyloxy-2-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Butanoyloxy-2-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C19H38NO8P (439.2335)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] decanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] decanoate

C19H38NO8P (439.2335)


   

eoxin E4

eoxin E4

C23H37NO5S (439.2392)


A leukotriene that is the 14R-(S-cysteinyl),15S-hydroxy derivative of (5Z,8Z,10E,12E)-icosa-7,9,11,14-tetraenoic acid.

   

MePC(10:0)

MePC(4:0_6:0)

C19H38NO8P (439.2335)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   

ST 24:6;O3;Gly

ST 24:6;O3;Gly

C26H33NO5 (439.2359)


   
   

CP-868388 (free base)

CP-868388 (free base)

C26H33NO5 (439.2359)


CP-868388 free base is a potent, selective and orally active PPARα agonist with a Ki value of 10.8 nM. CP-868388 free base has little or no affinity for PPARβ (Ki of 3.47 μM) and PPARγ. CP-868388 free base has hypolipidemic and anti-inflammatory actions[1].

   

Denifanstat

Denifanstat

C27H29N5O (439.2372)


Denifanstat (TVB-2640) is an orally active and potent Fatty Acid Synthase (FASN) inhibitor with an IC50 of 0.052 μM and an EC50 of 0.072 μM. Denifanstat has the potential for fatty liver disease and cancer research[1][2].

   

(1s,10s,11r,13s,14s,15s)-14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(1s,10s,11r,13s,14s,15s)-14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C26H33NO5 (439.2359)


   

(4e)-n-[(2e)-3-chloro-2-(3-hydroxy-6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

(4e)-n-[(2e)-3-chloro-2-(3-hydroxy-6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

C24H38ClNO4 (439.2489)


   

n-[3-chloro-2-(3-hydroxy-6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

n-[3-chloro-2-(3-hydroxy-6-oxocyclohex-1-en-1-yl)prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

C24H38ClNO4 (439.2489)


   

14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C26H33NO5 (439.2359)


   

(4e,7s)-n-[(2e)-3-chloro-2-[(3s)-3-hydroxy-6-oxocyclohex-1-en-1-yl]prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

(4e,7s)-n-[(2e)-3-chloro-2-[(3s)-3-hydroxy-6-oxocyclohex-1-en-1-yl]prop-2-en-1-yl]-7-methoxytetradec-4-enimidic acid

C24H38ClNO4 (439.2489)


   

5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-6,8,10-trimethyldodeca-2,4,6-trienoyl]-1,2-dihydropyrrol-3-one

5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-6,8,10-trimethyldodeca-2,4,6-trienoyl]-1,2-dihydropyrrol-3-one

C26H33NO5 (439.2359)


   

(2s,4z)-5-hydroxy-2-[(s)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2h-pyrrol-3-one

(2s,4z)-5-hydroxy-2-[(s)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2h-pyrrol-3-one

C26H33NO5 (439.2359)


   

(3e,17e)-5,16,22-trihydroxy-6,11,15-triazaspiro[bicyclo[17.3.1]tricosane-2,1'-cyclohexane]-1(23),3,5,15,17,19,21-heptaen-4'-one

(3e,17e)-5,16,22-trihydroxy-6,11,15-triazaspiro[bicyclo[17.3.1]tricosane-2,1'-cyclohexane]-1(23),3,5,15,17,19,21-heptaen-4'-one

C25H33N3O4 (439.2471)


   

5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-(1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene)-2h-pyrrol-3-one

5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-(1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene)-2h-pyrrol-3-one

C26H33NO5 (439.2359)


   

(1r,2r,3s,4r,4ar,8ar)-2-hydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-1,2,3,4a,5,6-hexahydronaphthalen-1-yl pyridine-3-carboxylate

(1r,2r,3s,4r,4ar,8ar)-2-hydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-1,2,3,4a,5,6-hexahydronaphthalen-1-yl pyridine-3-carboxylate

C26H33NO5 (439.2359)


   

(4z)-5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2h-pyrrol-3-one

(4z)-5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2h-pyrrol-3-one

C26H33NO5 (439.2359)


   

7-{[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-(acetyloxy)-1,3-benzoxazol-6-yl acetate

7-{[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-5-(acetyloxy)-1,3-benzoxazol-6-yl acetate

C26H33NO5 (439.2359)


   

(1s,10s,11r,13s,14r,15s)-14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(1s,10s,11r,13s,14r,15s)-14-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C26H33NO5 (439.2359)


   

5-hydroxy-3-{[7-(2-hydroxy-3-methoxy-3-methylbutyl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6-methyl-1,6-dihydropyrazin-2-one

5-hydroxy-3-{[7-(2-hydroxy-3-methoxy-3-methylbutyl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6-methyl-1,6-dihydropyrazin-2-one

C25H33N3O4 (439.2471)


   

5,16,22-trihydroxy-6,11,15-triazaspiro[bicyclo[17.3.1]tricosane-2,1'-cyclohexane]-1(23),3,5,15,17,19,21-heptaen-4'-one

5,16,22-trihydroxy-6,11,15-triazaspiro[bicyclo[17.3.1]tricosane-2,1'-cyclohexane]-1(23),3,5,15,17,19,21-heptaen-4'-one

C25H33N3O4 (439.2471)


   

(3z,6s)-3-({7-[(2s)-2-hydroxy-3-methoxy-3-methylbutyl]-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl}methylidene)-6-methyl-6h-pyrazine-2,5-diol

(3z,6s)-3-({7-[(2s)-2-hydroxy-3-methoxy-3-methylbutyl]-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl}methylidene)-6-methyl-6h-pyrazine-2,5-diol

C25H33N3O4 (439.2471)


   

(2r,4z)-5-hydroxy-2-[(r)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2h-pyrrol-3-one

(2r,4z)-5-hydroxy-2-[(r)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6e,8r,10r)-1-hydroxy-6,8,10-trimethyldodeca-2,4,6-trien-1-ylidene]-2h-pyrrol-3-one

C26H33NO5 (439.2359)